Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?

Julien Edeline, David Malka

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)3667-3668
Number of pages2
JournalJournal of Clinical Oncology
Volume40
Issue number31
DOIs
StatePublished - 1 Nov 2022
Externally publishedYes

Cite this